Freeze Dryers Gea Invests 70 Million Euros for Developing Pharma Technology Center

Related Vendors

Glatt Ingenieurtechnik GmbH

TRM Filter d.o.o.

Frewitt fabrique de machines SA

GEA Lyophil (Beijing

Gea will develop the new pharma technology center for freeze dryers in Elsdorf, Germany which is expected to boost growth and innovation in the vital pharma sector. The company is building a second ‘Factory of the Future’ which is based on modular and digital production structures.

Düsseldorf/Germany – Gea is investing 70 million euros in the construction of a new pharmaceutical technology center for freeze dryers in Elsdorf in the German state of North Rhine-Westphalia. Spread across some 40,000 m², the new facility, which is scheduled for completion by 2024, will stimulate better innovation opportunities and further growth in the attractive freeze-drying pharmaceuticals market. This process is essential to manufacturing a wide variety of injectable pharmaceutical products, such as vaccines.

“With our Mission 26 strategy, we aim to spur our profitable growth by offering sustainable solutions for the food and pharmaceutical industries,” says CEO Stefan Klebert. “Given how the new pharmaceutical technology center will leverage Gea’s full potential in the growing pharmaceutical sector, this investment dovetails perfectly with Mission 26.”

Since the current plant in Hürth, North Rhine-Westphalia, has reached its capacity limit, all areas, from development through design and production to assembly and services will relocate to the new site. Construction will get underway in 2023. All of the approximately 250 employees will relocate to the new nearby plant.

Following the construction of the first newly designed site in Koszalin (Poland), which started production this year, the second ‘Gea Factory of the Future’ is being built in Elsdorf. The concept is based on modular and digital production structures that ensure maximum flexibility while maintaining productivity, thus making a significant contribution to the growth strategy in the pharmaceutical sector.

Construction work on the new site will adhere to the highest sustainability standards (e.g. dedicated power generation, carbon neutrality) and implement innovative new digital solutions at every link in the value chain.

“Our Factory of the Future concept is instrumental to driving corporate growth and securing long-term competitiveness,” says COO Johannes Giloth. “Elsdorf will set new benchmarks for optimizing our global production network and its performance.”

(ID:48560064)